|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
EP0641781B1
(en)
|
1991-09-06 |
2000-07-26 |
Yoshitomi Pharmaceutical Industries, Ltd. |
4-amino(alkyl)cyclohexane-1-carboxamide compound and use thereof
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
US5824837A
(en)
|
1993-07-22 |
1998-10-20 |
Merck & Co., Inc. |
Expression of human interleukin-1β in a transgenic animal
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
|
ATE483733T1
(de)
|
1995-06-14 |
2010-10-15 |
Univ California |
Hochaffine humane antikörper gegen tumorantigene
|
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
|
IL128456A0
(en)
|
1996-08-12 |
2000-01-31 |
Yoshitomi Pharmaceutical |
Compositions containing a Rho kinase inhibitor
|
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
|
WO1998050048A1
(en)
|
1997-05-07 |
1998-11-12 |
Pharma Mar, S.A. |
Aplidine as an l-type calcium channel enhancer
|
|
CA2292339A1
(en)
|
1997-06-13 |
1998-12-17 |
Ludwig Institute For Cancer Research |
Smad6 and uses thereof
|
|
BR9810366A
(pt)
|
1997-07-01 |
2000-08-29 |
Warner Lambert Co |
Derivados de ácido 4-bromo ou 4-iodo fenilamino benzidroxîmico e seu uso como inibidores de mek
|
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
CA2336220A1
(en)
|
1998-07-24 |
2000-02-03 |
The Carnegie Institution Of Washington |
Method for maintenance and propagation of germline stem cells using members of the tgf-.beta. family of growth factors
|
|
GB9819912D0
(en)
|
1998-09-11 |
1998-11-04 |
Univ Edinburgh |
Propagation and/or derivation of embryonic stem cells
|
|
ATE292462T1
(de)
|
1999-01-07 |
2005-04-15 |
Warner Lambert Co |
Behandlung von asthma anhand von mek-inhibitoren
|
|
US6703420B1
(en)
|
1999-03-19 |
2004-03-09 |
Bristol-Myers Squibb Pharma Company |
Amino-thio-acrylonitriles as MEK inhibitors
|
|
AU5250400A
(en)
|
1999-06-18 |
2001-01-09 |
Mitsubishi Pharma Corporation |
Osteogenesis promoters
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
AU6865100A
(en)
|
1999-09-02 |
2001-04-10 |
Mitsubishi Pharma Corporation |
Osteogenesis promoting agents
|
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
|
YU2503A
(sh)
|
2000-07-19 |
2006-05-25 |
Warner-Lambert Company |
Oksigenovani estri 4-jodo fenilamino benzhidroksamskih kiselina
|
|
ATE353889T1
(de)
|
2001-03-23 |
2007-03-15 |
Bayer Pharmaceuticals Corp |
Rho-kinase inhibitoren
|
|
WO2002076976A2
(en)
|
2001-03-23 |
2002-10-03 |
Bayer Corporation |
Rho-kinase inhibitors
|
|
DE60234824D1
(de)
|
2001-05-01 |
2010-02-04 |
Ca Nat Research Council |
Induzierbares expressionssystem in eukaryotischen zellen
|
|
WO2003027277A1
(en)
|
2001-09-21 |
2003-04-03 |
Japan Science And Technology Corporation |
Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
|
|
ES2388968T3
(es)
|
2001-11-02 |
2012-10-22 |
Giuliani International Limited |
Inhibidores de Smad7 para el tratamiento de enfermedades del SNC
|
|
CA2472619A1
(en)
|
2002-01-10 |
2003-07-24 |
Bayer Corporation |
Fused pyrimidine derivates as rho-kinase inhibitors
|
|
EP1470121B1
(en)
|
2002-01-23 |
2012-07-11 |
Bayer HealthCare LLC |
Pyrimidine derivatives as rho-kinase inhibitors
|
|
EP1470122B1
(en)
|
2002-01-23 |
2007-12-19 |
Bayer Pharmaceuticals Corporation |
Rho-kinase inhibitors
|
|
DE60301953T2
(de)
|
2002-03-05 |
2006-07-27 |
Artemis Pharmaceuticals Gmbh |
Durch inzucht erzeugte von embryonalen stammzellen abgeleitete mäuse
|
|
TWI350285B
(en)
|
2002-03-13 |
2011-10-11 |
Array Biopharma Inc |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
|
EP1500643A4
(en)
|
2002-04-03 |
2007-03-28 |
Dainippon Sumitomo Pharma Co |
BENZAMIDE DERIVATIVES
|
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
|
EP1562935B1
(de)
|
2002-10-28 |
2006-09-06 |
Bayer HealthCare AG |
Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren
|
|
CA2506085A1
(en)
|
2002-11-15 |
2004-06-03 |
Ronald Lynn Merriman |
Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer
|
|
PT2457999T
(pt)
|
2002-12-16 |
2019-01-28 |
Technion Res & Dev Foundation |
Sistema de cultura para células estaminais pluripotentes
|
|
AU2004212490B2
(en)
|
2003-02-10 |
2008-05-15 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
|
US20050075276A1
(en)
|
2003-03-14 |
2005-04-07 |
Christopher Rudd |
Use of inhibitors of glycogen synthase-3 to augment CD28 dependent -T-cell responses
|
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
|
AU2004316996A1
(en)
|
2003-06-20 |
2005-09-15 |
The Regents Of The University Of California |
Polypeptide transduction and fusogenic peptides
|
|
RU2392315C2
(ru)
|
2003-10-03 |
2010-06-20 |
Кейити ФУКУДА |
Способ индукции дифференциации стволовых клеток в миокардиальные
|
|
TWI344961B
(en)
|
2003-10-15 |
2011-07-11 |
Ube Industries |
Novel indazole derivative
|
|
EP1673444A2
(en)
|
2003-10-16 |
2006-06-28 |
The University Court Of The University Of Edinburgh |
Control of es cell self-renewal and lineage specification, and medium therefor
|
|
US20070141703A1
(en)
|
2003-11-19 |
2007-06-21 |
Stanley Edouard G |
Methods for producing blood products from pluripotent cells in cell culture
|
|
ES2369835T3
(es)
|
2003-11-19 |
2011-12-07 |
Array Biopharma, Inc. |
Inhibidores bicíclicos de mek y métodos de síntesis de los mismos.
|
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
|
US20080275062A1
(en)
|
2004-01-30 |
2008-11-06 |
David Harold Drewry |
Chemical Compounds
|
|
US7585844B2
(en)
|
2004-04-21 |
2009-09-08 |
The University Of Chicago |
Myosin light chain kinase inhibitors and methods of use
|
|
KR20070083559A
(ko)
|
2004-08-13 |
2007-08-24 |
더 유니버시티 오브 죠지아 리서치 파운데이션, 인코포레이티드 |
인간 배아 줄기세포에서의 자가재생 및 분화를 위한 조성물및 방법
|
|
US20080268533A1
(en)
|
2004-08-25 |
2008-10-30 |
University Of Georgia Research Foundation, Inc. |
Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells
|
|
US20060182724A1
(en)
|
2005-02-15 |
2006-08-17 |
Riordan Neil H |
Method for expansion of stem cells
|
|
EP2361905B1
(en)
|
2005-05-18 |
2013-03-06 |
Array Biopharma Inc. |
Heterocyclic Inhibitors of MEK and methods of use thereof
|
|
US7601699B2
(en)
|
2005-08-01 |
2009-10-13 |
Nupotential, Inc. |
Production of reprogrammed cells with restored potential
|
|
CA2621161A1
(en)
|
2005-09-08 |
2007-03-15 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Methods for promoting stem cell proliferation and survival
|
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
|
AU2006325975B2
(en)
|
2005-12-13 |
2011-12-08 |
Kyoto University |
Nuclear reprogramming factor
|
|
US20090227032A1
(en)
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
|
GB0601538D0
(en)
|
2006-01-26 |
2006-03-08 |
Univ Birmingham |
Epigenetic analysis
|
|
JPWO2007088651A1
(ja)
|
2006-02-01 |
2009-06-25 |
国立大学法人 東京大学 |
ＴＧＦ−βシグナル阻害剤と抗腫瘍剤の組み合せ使用
|
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
|
US9074180B2
(en)
|
2006-03-30 |
2015-07-07 |
The University Court Of The University Of Edinburgh |
Culture medium containing kinase inhibitors, and uses thereof
|
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
|
GB2452186B
(en)
|
2006-05-02 |
2011-01-26 |
Wisconsin Alumni Res Found |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
|
US20070298496A1
(en)
|
2006-06-23 |
2007-12-27 |
Hung-Chih Kuo |
Method of deriving pluripotent stem cells from a single blastomere
|
|
JP2009542666A
(ja)
|
2006-06-30 |
2009-12-03 |
シェーリング コーポレイション |
Ｐ５３活性を増加させる置換ピペリジンおよびその使用
|
|
EP2044056B1
(en)
|
2006-07-14 |
2012-08-22 |
Novartis AG |
Pyrimidine derivatives as alk-5 inhibitors
|
|
US20080020014A1
(en)
|
2006-07-19 |
2008-01-24 |
Paul Consigny |
Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
|
|
ZA200901914B
(en)
|
2006-09-22 |
2010-06-30 |
Riken |
Stem cell culture medium and method
|
|
JP2008099662A
(ja)
|
2006-09-22 |
2008-05-01 |
Institute Of Physical & Chemical Research |
幹細胞の培養方法
|
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
|
WO2008089351A1
(en)
|
2007-01-17 |
2008-07-24 |
Wisconsin Alumni Research Foundation |
Improved culture of stem cells
|
|
US20100172883A1
(en)
|
2007-01-19 |
2010-07-08 |
Bruneau Benoit Gaetan |
Methods of generating cardiomyocytes
|
|
CN103627671A
(zh)
|
2007-01-30 |
2014-03-12 |
佐治亚大学研究基金会 |
产生中内胚层细胞及多能游走细胞的方法与细胞群及用途
|
|
US8158415B2
(en)
|
2007-02-27 |
2012-04-17 |
Procell Therapeutics Inc. |
Combined use of cell permeable Nanog and Oct4 for increasing self-renewal and suppressing differentiation of stem cells
|
|
ES2703592T3
(es)
|
2007-03-07 |
2019-03-11 |
Mei Pharma Inc |
Combinación de agente anticancerígeno de bencimidazol y un segundo agente anticancerígeno
|
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
|
WO2008129554A1
(en)
|
2007-04-18 |
2008-10-30 |
Hadasit Medical Research Services & Development Limited |
Stem cell-derived retinal pigment epithelial cells
|
|
US7878210B2
(en)
|
2007-06-04 |
2011-02-01 |
Philip Morris Usa Inc. |
Cellulose acetate fiber modification
|
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
|
KR20160005142A
(ko)
|
2007-06-29 |
2016-01-13 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
배아줄기세포 배양을 위한 자동화 방법 및 장치
|
|
WO2009032456A2
(en)
|
2007-08-01 |
2009-03-12 |
Primegen Biotech Llc |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
|
EP3078738B1
(en)
|
2007-08-31 |
2020-05-20 |
Whitehead Institute for Biomedical Research |
Wnt pathway stimulation in reprogramming somatic cells
|
|
CA2660123C
(en)
|
2007-10-31 |
2017-05-09 |
Kyoto University |
Nuclear reprogramming method
|
|
US20110151447A1
(en)
|
2007-11-06 |
2011-06-23 |
Children's Medical Center Corporation |
Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells
|
|
JP4604076B2
(ja)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
燃料電池用電解質膜
|
|
EP2227540A4
(en)
|
2007-11-29 |
2011-11-02 |
Children S Hospital Of Orange County |
DIFFERENTIATION OF HUMAN CELLS
|
|
US20110190730A1
(en)
|
2007-11-30 |
2011-08-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving oct4 protein
|
|
US20110190729A1
(en)
|
2007-11-30 |
2011-08-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving sox2 protein
|
|
WO2009117439A2
(en)
|
2008-03-17 |
2009-09-24 |
The Scripps Research Institute |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
|
EP2268796A1
(en)
|
2008-03-17 |
2011-01-05 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination
|
|
CN101550406B
(zh)
|
2008-04-03 |
2016-02-10 |
北京大学 |
制备多潜能干细胞的方法,试剂盒及用途
|
|
CN102083982A
(zh)
*
|
2008-04-07 |
2011-06-01 |
纽珀滕索有限公司 |
通过rna干扰引入复能基因而重编程细胞
|
|
EP2128245A1
(en)
*
|
2008-05-27 |
2009-12-02 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Generation of induced pluripotent stem (iPS) cells
|
|
EP2307539B1
(en)
|
2008-07-30 |
2014-11-19 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
|
EP2331696A1
(en)
|
2008-08-12 |
2011-06-15 |
Cellular Dynamics International, Inc. |
Methods for the production of ips cells
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
CN102361970B
(zh)
|
2008-11-04 |
2018-03-27 |
韦尔赛特公司 |
干细胞聚集体悬浮组合物及其分化方法
|
|
SG196784A1
(en)
|
2008-12-03 |
2014-02-13 |
Scripps Research Inst |
Stem cell cultures
|
|
CA2688804A1
(en)
|
2008-12-17 |
2010-06-17 |
The Uab Research Foundation |
Polycistronic vector for human induced pluripotent stem cell production
|
|
SG172160A1
(en)
|
2008-12-17 |
2011-07-28 |
Scripps Research Inst |
Generation and maintenance of stem cells
|
|
US20120122212A1
(en)
|
2009-03-06 |
2012-05-17 |
Marica Grskovic |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
|
KR20110134939A
(ko)
|
2009-04-03 |
2011-12-15 |
더 맥클린 하스피털 코퍼레이션 |
유도된 다능성 줄기 세포
|
|
WO2010120785A2
(en)
|
2009-04-13 |
2010-10-21 |
The Regents Of The University Of California |
Methods and compositions for stem cell cultures
|
|
EP2435558A4
(en)
|
2009-05-27 |
2013-05-22 |
Salk Inst For Biological Studi |
GENETICALLY CORRECTED NON-DISABLED INDUCED PLURIPOTENTER STEM CELLS
|
|
US8524498B2
(en)
|
2009-05-29 |
2013-09-03 |
The General Hospital Corporation |
Methods and compositions for homologous recombination in human cells
|
|
JP5777113B2
(ja)
|
2009-05-29 |
2015-09-09 |
学校法人慶應義塾 |
人工多能性幹細胞のクローンの選択方法
|
|
KR101774206B1
(ko)
|
2009-08-07 |
2017-09-04 |
고쿠리츠 다이가쿠 호진 교토 다이가쿠 |
유도된 다능성 줄기 세포의 효율적인 확립 방법
|
|
CA3091210C
(en)
|
2009-10-16 |
2023-04-04 |
The Scripps Research Institute |
Induction of pluripotent cells
|
|
EP2494039B1
(en)
|
2009-10-31 |
2019-06-19 |
Genesis Technologies Limited |
Methods for reprogramming cells and uses thereof
|
|
AU2010315166B2
(en)
|
2009-11-04 |
2015-01-22 |
FUJIFILM Cellular Dynamics, Inc. |
Episomal reprogramming with chemicals
|
|
ES2779048T3
(es)
|
2009-11-12 |
2020-08-13 |
Technion Res & Dev Foundation |
Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en un estado indiferenciado
|
|
US10485829B2
(en)
*
|
2009-11-17 |
2019-11-26 |
Astellas Institute For Regenerative Medicine |
Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells
|
|
JP5827220B2
(ja)
|
2010-01-22 |
2015-12-02 |
国立大学法人京都大学 |
人工多能性幹細胞の樹立効率改善方法
|
|
AU2011218041B2
(en)
*
|
2010-02-17 |
2015-12-17 |
Lineage Cell Therapeutics, Inc. |
Methods for telomere length and genomic DNA quality control analysis in pluripotent stem cells
|
|
ES2533581T3
(es)
|
2010-03-05 |
2015-04-13 |
Texas Heart Institute |
ETS2 y Mesp1 generadores de progenitores cardíacos a partir de fibroblastos
|
|
ES2893699T3
(es)
|
2010-03-31 |
2022-02-09 |
Scripps Research Inst |
Reprogramación de células
|
|
US20110306516A1
(en)
|
2010-06-15 |
2011-12-15 |
The New York Stem Cell Foundation |
Methods for producing induced pluripotent stem cells
|
|
US8691574B2
(en)
|
2010-06-15 |
2014-04-08 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
|
WO2011158852A1
(ja)
|
2010-06-15 |
2011-12-22 |
国立大学法人東京大学 |
誘導型多能性幹細胞の製造方法
|
|
US8765470B2
(en)
|
2010-08-04 |
2014-07-01 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized B-cells to induced pluripotent stem cells
|
|
KR20140063501A
(ko)
|
2010-12-22 |
2014-05-27 |
페이트 세러퓨틱스, 인코포레이티드 |
단세포 분류 및 iPSC의 증강된 재프로그래밍을 위한 세포 배양 플랫폼
|
|
WO2013070852A2
(en)
|
2011-11-08 |
2013-05-16 |
Emory University |
Compounds and compositions used to epigenetically transform cells and methods related thereto
|
|
AU2012347534B2
(en)
|
2011-12-08 |
2018-01-25 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
|
|
WO2013159103A1
(en)
|
2012-04-20 |
2013-10-24 |
Whitehead Institute For Biomedical Research |
Programming and reprogramming of cells
|
|
WO2013176197A1
(ja)
|
2012-05-22 |
2013-11-28 |
国立大学法人 東京大学 |
抗原特異的ｔ細胞の製造方法
|
|
US9166832B1
(en)
|
2013-10-04 |
2015-10-20 |
Altera Corporation |
Methods and apparatus for decision feedback equalization adaptation
|
|
ES2966757T3
(es)
|
2014-03-04 |
2024-04-24 |
Fate Therapeutics Inc |
Métodos de reprogramación mejorados y plataformas de cultivo celular
|
|
SG10202111851YA
(en)
|
2015-10-16 |
2021-12-30 |
Fate Therapeutics Inc |
Platform for the Induction & Maintenance of Ground State Pluripotency
|
|
PT3371314T
(pt)
*
|
2015-11-04 |
2023-08-31 |
Fate Therapeutics Inc |
Modificação genómica de células pluripotentes
|